On June 25, 2025, the U.S. Department of the Treasury's Financial Crimes Enforcement Network ("FinCEN") issued three orders designating CIBanco S.A., Intercam Banco S.A., and Vector Casa de Bolsa, S.A. de C.V. (collectively, the "Designated Institutions") as "financial institutions of primary money laundering concern." These measures, taken under the FEND Off Fentanyl Act of 2024, target the entities' role in laundering proceeds linked to opioid trafficking and restrict U.S. financial institutions from transacting with them. The prohibitions will take effect 21 days after their publication in the Federal Register.
Legislative Authority and Background
The legislative foundation for these actions stems from the FEND Off Fentanyl Act, enacted to address the growing crisis of synthetic opioid trafficking, particularly fentanyl, which has significantly impacted the U.S. (See our previous blog post, located here.) The Act empowers the Secretary of the Treasury to designate foreign financial institutions as primary money laundering concerns when these entities are linked to opioid trafficking activities. Under this framework, FinCEN is authorized to impose "special measures" as described in 31 U.S.C. 5318A(b) and 21 U.S.C. 2313a. These measures can include prohibitions or conditions on transactions involving the designated institutions, creating a mechanism to disrupt illicit financial flows and safeguard the integrity of the U.S. financial system.
Building on this legislative foundation, FinCEN has targeted specific institutions due to their involvement in illicit activities.
Designation of Mexican Financial Institutions
FinCEN's investigation determined that each of the designated institutions facilitated illicit financial flows for Mexican drug trafficking organizations ("DTO"s), including the Jalisco New Generation Cartel, the Sinaloa Cartel, and the Gulf Cartel. The findings include:
- CIBanco S.A., Institución de Banca Múltiple: Identified as having substantial ties to DTOs, which utilize its financial services to facilitate money laundering operations. Despite assertions from CIBanco regarding its anti-money laundering ("AML") compliance measures, FinCEN's investigation revealed significant gaps and inadequacies in its AML framework. Evidence points to CIBanco's involvement in processing considerable funds that are subsequently channeled into DTO operations, supporting illicit opioid trafficking activities.
- Intercam Banco S.A., Institución de Banca Múltiple: Offering a range of financial services and maintains USD correspondent banking relationships with multiple U.S. financial institutions. According to FinCEN's findings, Intercam has played a role in processing funds related to the importation of precursor chemicals necessary for the synthesis of synthetic opioids. The investigation indicated that Intercam had been persistently involved in money laundering activities tied to DTOs, underscoring its critical role in facilitating complex financial flows that support the drug trade.
- Vector Casa de Bolsa, S.A. de C.V.: Implicated in processing transactions for DTOs, including high-profile groups such as the Sinaloa and Gulf Cartels. Despite having an AML/CFT compliance program, FinCEN's analysis revealed that Vector has facilitated ongoing transactions that benefit DTO operations. Its services reportedly involved processing funds associated with the importation of precursor chemicals and laundering profits back into Mexico, further entrenching its role in the illicit financial network.
Although the orders focus on operations located in Mexico, the practical effects will be felt by financial institutions globally, particularly U.S. firms with correspondent banking or payment relationships involving these entities.
Details of Prohibitions and Effective Dates
FinCEN's orders prohibit all covered U.S. financial institutions from engaging in any transmittal of funds to or from the Designated Institutions. This includes:
- Wire transfers
- ACH transactions
- Convertible virtual currency transfers
- Any payment involving accounts or intermediaries administered by these institutions
Notably, these measures are civil in nature, but violations could trigger significant civil or criminal penalties under the Bank Secrecy Act and related statutes.
The orders are scheduled to become effective 21 days after publication in the Federal Register. While publication is still pending, U.S. financial institutions are expected to begin preparing immediately to comply with the prohibitions. The orders specify no expiration date but may be modified or rescinded in the future under certain conditions, such as litigation outcomes or resolution of underlying concerns.
Scope and Application of Restrictions
The prohibitions apply to:
- The specified entities' operations within Mexico
- Any account or address (including crypto wallets) administered on behalf of those entities
They do not apply to the Designated Institutions' branches or subsidiaries located outside Mexico, such as in the U.S.—but financial institutions should remain cautious of indirect exposures.
Rationale Behind FinCEN's Action
The FEND Off Fentanyl Act authorizes Treasury to target foreign institutions facilitating illicit opioid trafficking. According to Treasury, these designations are part of a broader national security and public health strategy to combat the synthetic opioid crisis by cutting off DTOs from the global financial system.
DTOs often rely on sophisticated cross-border financial channels—including legitimate institutions—to launder proceeds from trafficking. The designations serve to disrupt those networks and signal the U.S. government's zero-tolerance stance on enabling illicit drug finance.
Immediate Actions for Financial Institutions
U.S. financial institutions must take immediate compliance actions:
- Screen for exposure: Review existing clients, counterparties, and transactions to identify any links to the Designated Institutions.
- Update internal controls: Modify AML/CFT protocols, enhance transaction screening tools, and adjust payment routing mechanisms.
- Reassess relationships: Evaluate correspondent banking ties and terminate or revise any arrangements involving the Designated Institutions.
- Conduct training: Educate compliance teams and staff on the scope of the orders and risk of inadvertent violations.
- Monitor updates: Stay alert for FAQs, clarifications, and guidance from FinCEN and other U.S. regulatory authorities.
Final Thoughts
FinCEN's unprecedented use of Section 2313a authority under the FEND Off Fentanyl Act underscores a new era in countering global drug finance. The designations of CIBanco, Intercam, and Vector aim to cut off the financial lifelines of DTOs and disrupt illicit opioid flows into the U.S. U.S. financial institutions must act swiftly to ensure compliance—not only to avoid regulatory penalties, but also to safeguard the integrity of the global financial system.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
